Clinical trials
Phase 1/2 Colorectal Neoplasms trials in China
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
79 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2009 | 2 |
| 2012 | 2 |
| 2014 | 3 |
| 2015 | 3 |
| 2016 | 5 |
| 2017 | 3 |
| 2018 | 3 |
| 2019 | 5 |
| 2020 | 5 |
| 2021 | 4 |
| 2022 | 6 |
| 2023 | 7 |
| 2024 | 9 |
| 2025 | 7 |
| 2026 | 15 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 26 |
| Unknown status | 17 |
| Completed | 15 |
| Active, not recruiting | 9 |
| Not yet recruiting | 8 |
| Withdrawn | 2 |
| Terminated | 1 |
| Enrolling by invitation | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Sun Yat-sen University | 6 |
| Essen Biotech | 3 |
| Fuda Cancer Hospital, Guangzhou | 3 |
| Betta Pharmaceuticals Co., Ltd. | 2 |
| Chinese Academy of Medical Sciences | 2 |
| Chinese PLA General Hospital | 2 |
| Fudan University | 2 |
| Genfleet Therapeutics (Shanghai) Inc. | 2 |
| Jacobio Pharmaceuticals Co., Ltd. | 2 |
| Novartis Pharmaceuticals | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Colorectal Neoplasms | 79 |
| Carcinoma, Non-Small-Cell Lung | 14 |
| Pancreatic Neoplasms | 13 |
| Stomach Neoplasms | 12 |
| Breast Neoplasms | 11 |
| Lung Neoplasms | 11 |
| Ovarian Neoplasms | 10 |
| Neoplasms | 9 |
| Carcinoma, Hepatocellular | 7 |
| Liver Neoplasms | 6 |
Trials
Showing 1 to 25 of 79. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.